Overnight I received a reply to my email to Matt Lehman, posted below:
"Dear xxxx, thanks for the note.
Nothing has changed with the status or designation of the CANVAS trial (except initiation of new sites as announced). It seems that there are database entry and design limitations with clinicaltrials.gov that arose with the most recent updates to the website. The team is on it and I expect this can be corrected in the next 1-2 weeks."
That should clear this matter up for us all.
Cheers
K
Overnight I received a reply to my email to Matt Lehman, posted...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.040(11.9%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 33.0¢ | 28.0¢ | $7.278M | 23.75M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 53192 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 41048 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |